我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

厄贝沙坦对SHR左心室肥厚和心肌纤维化的影响

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2009年第2期
页码:
190-192/196
栏目:
基础研究
出版日期:
2009-03-30

文章信息/Info

Title:
Effects of Irbesartan on left ventricular hypertrophy and myocardial fibrosis in SHR
作者:
朱伟旺; 赵凤琴
惠州市中心人民医院急救创伤中心,广东 惠州 516001
Author(s):
ZHU Wei-wang;  ZHAO Feng-qin
Central of Emergency and Trauma, Huizhou Municipal Contral Hospital, Huizhou 516001, Guangdong, China
关键词:
厄贝沙坦; 大鼠; 左室肥厚; 心肌纤维化
Keywords:
Irbesartan;  rats;  left ventricular hypertrophy;  myocardial fibrosis
分类号:
R972
DOI:
-
文献标识码:
A
摘要:
目的 探讨厄贝沙坦对自发性高血压大鼠(SHR)左心室肥厚(LVH)和心肌纤维化的影响。方法 16只16周龄雄性SHR，随机分为厄贝沙坦治疗组和SHR空白对照组；另设同源的WKY大鼠8只为正常对照组。治疗组予厄贝沙坦15 mg/（kg·d）灌胃给药，8周后处死动物，测量左心室心肌厚度并称质量，计算左心室质量/体质量比(LVM/BM)；通过Van Gieson染色法观察左心室心肌胶原变化，对左心室心肌胶原容积分数(CVF)和血管周围胶原面积(PVCA)进行定性和半定量分析；HE染色光镜观察左心室心肌病理变化。结果 与WKY组相比，SHR对照组的尾动脉收缩压(SBP)、LVM/BM、左心室壁厚度、CVF、PVCA、均显著增高(P<0.01)；与SHR对照组相比，厄贝沙坦治疗组能有效降低SHR的SBP，改善LVH(P<0.01)，减少心肌间质及心肌小动脉周围的胶原(P<0.01)。结论 厄贝沙坦可有效降低SHR血压，减轻心肌纤维化和LVH。
Abstract:
AIM To explore the effects of Irbesartan on left ventricular hypertrophy and myocardial fibrosis in spontaneously hypertensive rats (SHR). METHODS Sixteen male SHR at 16 weeks of age were randomly divided into treatment group ［receiving Irbesartan 15 mg/(kg·d)］ and SHR-control group, and another 8 WKY rats were used as healthy contro1 group. After 8 weeks, all the rats were killed. The thickness of left ventricle was measured and the left ventricle muscle mass (LVM) was measured to calculate the LVM/BM. Myocardial collage was stained and the interstitial collagen volume fraction (CVF) and the perivascular circumferential collagen area (PVCA) were determined by quantitative morphometry. RESULTS Compared with those in WKY group, the SBP, LVW/BW, thickness of left ventricle, CVF and PVCA were significantly higher in SHR group (P<0.01). They substantially reduced in treatment group compared with those in SHR group (P<0.01). CONCLUSION Irbesartan effectively decreases blood pressure and inhibits myocardial fibrosis and left ventricle hypertrophy.

参考文献/References

[1］ Schillaci G， Verdecchia P, Porcellati C, et al. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension［J］. Hypertension, 2000, 35(2):580-586.

［2］ Conrad CH, Brooks WW, Hayes JA, et al. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat［J］. Circulation, 1995, 91(1):161-170.

［3］ 孙宁玲，王鸿懿，陈源源，等. EPK表达及活化在自发性高血压大鼠心肌肥厚中作用的研究［J］. 高血压杂志， 2002， 10(4):352-355.

［4］ Liu JJ, Peng L, Bradley CJ, et al. Increased apoptosis in the heart of genetic hypertension, associated with increased fibroblasts［J］. Cardiovasc Res, 2000, 45(3):729-735.

［5］ Makino N, Sugano M, Otsuka S, et al. Molecular mechanism of angiotensin Ⅱ typeⅠand type Ⅱreceptors in cardiac hypertrophy of spontaneously hypertensive rats［J］. Hypertension, 1997, 30(4):796-802.

［6］ 余国龙，梁晓秋，谢秀梅，等. 高血压大鼠心脏肥厚过程中心肌细胞凋亡心肌纤维化动态观察［J］. 高血压杂志， 2001， 9(4):322-325.

［7］ Rosendorff C.The rein-angiotensin system and vascular hypertrophy［J］. J Am Coll Cardiol, 1996, 28(4):803-812.

［8］ Brunner-La Rocca HP， Vaddadi G， Esler MD. Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-Ⅱantagonism［J］. JAmCollCardiol,1999,33(5):1163-1173.

［9］ 边瓯，陈富荣，陈铁锋，等. 自发性高血压大鼠左室重构过程中肝细胞生长因子与心肌纤维化的相关研究［J］. 心脏杂志， 2005, 17(4):323-325.

备注/Memo

备注/Memo:
收稿日期：2007-6-18.通讯作者：赵凤琴，教授, 主要从事心血管病研究Email：zhao666@263.net 作者简介：朱伟旺，硕士生Email：zww780202@sina.com
更新日期/Last Update: 2009-04-16